Cost Effectiveness of Meningococcal Serogroup B Vaccination in College-Aged Young Adults. [electronic resource]
Producer: 20200330Description: 196-204 p. digitalISSN:- 1873-2607
- Adolescent
- Age Factors
- Cost-Benefit Analysis -- statistics & numerical data
- Decision Trees
- Female
- Humans
- Male
- Mass Vaccination -- economics
- Meningococcal Infections -- economics
- Meningococcal Vaccines -- administration & dosage
- Models, Economic
- Neisseria meningitidis, Serogroup B -- immunology
- Quality-Adjusted Life Years
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.